Literature DB >> 17360863

Avian mortality surveillance for West Nile virus in Colorado.

Nicole M Nemeth1, Susan Beckett, Eric Edwards, Kaci Klenk, Nicholas Komar.   

Abstract

We tested 1,549 avian carcasses of 104 species to identify targets for West Nile virus (WNV) surveillance in Colorado, determine species affected by WNV, compare virus isolation versus RNA detection applied to hearts and oral swabs from carcasses, and compare the VecTest WNV Antigen Assay (VecTest) to standard assays. Forty-two species tested positive. From June to September 2003, 86% of corvids, 34% of non-corvid passerines, and 37% of raptors tested positive. We developed the Target Species Index, which identified American crows as the most important avian indicator species. However, testing multiple species maximizes detection, which may be important early and late in the transmission season. This index may benefit surveillance for other zoonotic pathogens, such as highly pathogenic avian influenza H5N1 virus. VecTest using oral swabs was most sensitive for American crow, black-billed magpie, house finch, house sparrow, and American kestrel. Wildlife rehabilitation centers should be recruited to enhance WNV surveillance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360863

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Short report: Antibody prevalence of select arboviruses in mute swans (Cygnus olor) in the Great Lakes region and Atlantic coast of the United States.

Authors:  Kerri Pedersen; David R Marks; Dustin M Arsnoe; Sarah N Bevins; Eryu Wang; Scott C Weaver; Randall M Mickley; Thomas J DeLiberto
Journal:  Am J Trop Med Hyg       Date:  2014-09-29       Impact factor: 2.345

Review 2.  Use of observed wild bird activity on poultry farms and a literature review to target species as high priority for avian influenza testing in 2 regions of Canada.

Authors:  Theresa E Burns; Carl Ribble; Craig Stephen; David Kelton; Lorraine Toews; Jason Osterhold; Hazel Wheeler
Journal:  Can Vet J       Date:  2012-02       Impact factor: 1.008

3.  West Nile virus in the British Virgin Islands.

Authors:  S J Anthony; M M Garner; L Palminteri; I Navarrete-Macias; M D Sanchez-Leon; T Briese; P Daszak; W I Lipkin
Journal:  Ecohealth       Date:  2014-02-07       Impact factor: 3.184

4.  An ex vivo avian leukocyte culture model for West Nile virus infection.

Authors:  Elizabeth A Dietrich; Richard A Bowen; Aaron C Brault
Journal:  J Virol Methods       Date:  2015-03-14       Impact factor: 2.014

5.  Bird community composition linked to human West Nile virus cases along the Colorado front range.

Authors:  Valerie J McKenzie; Nicolas E Goulet
Journal:  Ecohealth       Date:  2010-12-02       Impact factor: 3.184

6.  Predicted and observed mortality from vector-borne disease in small songbirds.

Authors:  A Marm Kilpatrick; Ryan J Peters; Alan P Dupuis; Matthew J Jones; Peter P Marra; Laura D Kramer
Journal:  Biol Conserv       Date:  2013-09-01       Impact factor: 5.990

7.  Experimental infection of raccoons (Procyon lotor) with West Nile virus.

Authors:  J Jeffrey Root; Kevin T Bentler; Nicole M Nemeth; Thomas Gidlewski; Terry R Spraker; Alan B Franklin
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

8.  Naturally induced humoral immunity to West Nile virus infection in raptors.

Authors:  Nicole M Nemeth; Gail E Kratz; Rebecca Bates; Judy A Scherpelz; Richard A Bowen; Nicholas Komar
Journal:  Ecohealth       Date:  2008-08-02       Impact factor: 3.184

9.  Humoral immunity to West Nile virus is long-lasting and protective in the house sparrow (Passer domesticus).

Authors:  Nicole M Nemeth; Paul T Oesterle; Richard A Bowen
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

10.  Predictive spatial models for risk of West Nile virus exposure in eastern and western Colorado.

Authors:  Anna M Winters; Rebecca J Eisen; Saul Lozano-Fuentes; Chester G Moore; W John Pape; Lars Eisen
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.